Today, US biotechnology firms dominate the growing therapeutics and diagnostics sectors
despite most of the key discoveries being made by European, and especially UK scientists …

The pharmaceutical industry remains powerful due to its firm scale and global reach.
However, analysis of the source of biotechnology-derived products in healthcare, valued at …

This paper's focus is on both the geography of entrepreneurship and on industry‐
collaborative links internationally, nationally and at the local level in the UK biotech industry …

This paper seeks to trace important shifts and cluster evolution in the healthcare industry. Its
key aim is to examine the implications of the rise of science-based clusters for economic …

This paper presents a case study of one of the most intensive biotechnology clusters in
Europe, Oxfordshire. Its purpose is to examine patterns of development, focusing on the …

Regional governments around the world hope to become significant players in the world
biotechnology industry through their support for local clusters. This article explores whether …

The dynamic growth of biotechnology in Germany in recent years has an obviously spatial
pattern. Some regions show a substantial potential for start-ups and young firms of this new …

The article examines the variety of linkages firms have established with university science.
These include using universities as a source of ideas for start-ups, scientific collaboration …

This paper provides a critical review of the literature on innovative clusters in biotechnology.
It examines the main contributions on this subject, trying to identify some robust stylised …

This Editorial introduces the Special Issue on 'Biotechnology Clusters and Beyond'. Drawing
on the interventions of five commissioned articles from Canada, Germany, Israel, the UK and …